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KCG KDG p value
Age at onset 7 (y) 2 (y) <0,0001
Maculo-papular rash 61,50% 39,60% 0,01
Diarrhea 52,80% 11,50% <0,0001
Tachypnea 22,60% 4,20% 0,001
Myocarditis 60,40% 3,10% <0,0001
ICU admission 23,10% 1,10% <0,0001
HLH 18,40% 1,20% 0,001
Lenght hospitalization 12 days 10 days 0,02
SARS-CoV-2 assay positive 75,50% 20% <0,0001LB001
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Introduction: Italy was affected by the SARS-CoV-2 epidemic after its
outbreak in China. With a 4-weeks delay after the peak in adults, we
observed an abnormal number of patients with characteristics of a
multi-inflammatory disease and similarities with Kawasaki Disease
(KD). Others reported similar cases, defined PIMS-TS or MIS-C.1,2
Objectives: To better characterize clinical features and treatment re-
sponse of PIMS-TS and to explore its relationship with KD.
Methods: We conducted an observational, retrospective, multicenter
study. On April 24th-2020 the Rheumatology Study Group of the Ital-
ian Pediatric Society launched a national online survey, to enroll pa-
tients diagnosed with KD or with a multisystem inflammatory disease
between February 1st 2020 and May 31st. The population was then
divided into two different groups: 1) Classical and incomplete KD,
named Kawasaki Disease Group (KDG); 2) KD-like multi-inflammatory
syndrome, named KawaCOVID (KCG). An expert panel of pediatric
rheumatologists re-analyzed every single patient to ensure appropri-
ate classification. Data were collected with an online database.
Results: 149 cases were studied, 96 with KDG and 53 with KCG. The
two population significantly differed for clinical characteristics (see© The Author(s). 2020 Open Access This artic
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data made available in this article, unless othetable 1). Lymphopenia, higher CRP levels, elevated Ferritin and
Troponin-T characterized KCG such as lower WBC and platelets
(all p values<0,05). KDG received more frequently immunoglobu-
lins (IVIG) and acetylsalicylic acid (ASA) (81,3% vs 66%; p=0.04
and 71,9% vs 43,4%; p=0.001 respectively) as KCG more often re-
ceived glucocorticoids (56,6% vs 14,6%; p<0.0001). SARS-CoV-2
assay more often resulted positive in KCG than in KDG (75,5% vs
20%; p<0.0001). Short-term follow data on KCG showed minor
complications while on KDG a majority of patients had persist-
ence of CAA. Comparing KDG with a KD-Historical Italian cohort
(598 patients), no statistical difference was found in terms of
clinical manifestations and laboratory data between the two
groups
Conclusion: Our study would suggest that SARS-CoV-2 infection might
determine two distinct inflammatory diseases in children: KD, possibly
triggered by SARS-CoV-2, and PIMS-TS. Older age at onset and clinical
peculiarities, like the occurrence of myocarditis, characterize this multi-
inflammatory syndrome. Our patients had an optimal response to treat-
ments and a good outcome, with few complications and no deaths.
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